OpenAlex
PricingAboutJobs
Log inGet started
Work

Elevated Serum HER-2/neu Level Predicts Decreased Response to Hormone Therapy in Metastatic Breast Cancer

HTML

Year: 2002
Type: article
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2002.20.6.1467
Authors: Allan Lipton, S.M. Ali, K. Leitzel, L. Demers, V. Chinchilli, L. Engle, Harold A. Harvey, C. Brady, C.M. Nalin, M. Dugan, W. Carney, J. Allard
Institutions: Penn State Milton S. Hershey Medical Center, Bayer (United States), Penn State Cancer Institute
Language: English

Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: HER2/neu, serum biomarkers, metastatic breast cancer, hormone therapy response, endocrine therapy, estrogen receptor-positive breast cancer, megestrol acetate, aromatase inhibitors, fadrozole, letrozole, time to progression, survival, predictive biomarkers
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2141217952
FWCI: 14.72
Cites: 25
Cited by: 266
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms